Dexcom G7

This is not medical advice. Always consult a licensed healthcare professional before starting or changing any treatment. Information here is based on personal experiences and may not apply to everyone.

Dexcom G7 is a next-generation continuous glucose monitor (CGM) designed for people with type 1 diabetes, offering real-time glucose readings with improved accuracy, convenience, and ease of use.

It features a small, all-in-one sensor and transmitter that is worn on the skin and replaced every 10 days. The sensor has a 30-minute warm-up time—the shortest among CGMs—and requires no fingerstick calibrations. Glucose data is sent automatically to a smartphone or compatible insulin pump and includes customizable alerts for high and low readings.

Dexcom G7 is FDA-approved for use in children and adults, integrates with automated insulin delivery systems like Tandem Control-IQ, and supports remote sharing with caregivers. It is a preferred option for patients seeking discreet, accurate, and responsive glucose monitoring.

Treatment Type: Device

Treatment Class: Continuous Glucose Monitor

Treatment Modality: N/A

Review Summary

0

0 Reviews

Preferred by 0 Reviewers

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost

1 = Very Expensive 5 = Very Affordable

0

Very Expensive

Relief Speed

1 = No Relief 5 = Immediate Relief

0

No Relief

Side Effects

1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect

Treatment Line

1 = Third-line or more 5 = First-line

0

Third-line or more

Choose treatments from the menu above to see how they compare side by side.

0

0 Reviews

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost

Very Expensive

$1000+

Expensive

$501 to $1000

Moderate Cost

$101 to $500

Affordable

$25 to $100

Very Affordable

$25

Relief Speed

No Relief

No noticeable improvement

Slow Relief

Several days to weeks

Moderate Relief

Within 1 - 3 days

Fast Relief

Within hours

Immediate Relief

Within minutes

Side Effect

Intolerable Side Effect

Caused treatment to stop or required hospitalization

Severe Side Effect

Difficult to tolerate, may require intervention

Moderate Side Effect

Noticeable, but manageable

Mild Side Effect

Minor, not bothersome

No Side Effect

Without any adverse effects

Treatment Line

Third-line or more

Used after second-line failed or multiple prior treatment

Second-line

Used after first-line treatment failed or was unsuitable

First-line

First treatment tried

No reviews yet.

Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.